載入...
Safety and effectiveness of pirfenidone combined with carboplatin‐based chemotherapy in patients with idiopathic pulmonary fibrosis and non‐small cell lung cancer: A retrospective cohort study
BACKGROUND: Pirfenidone is an antifibrotic agent that is potentially effective for the treatment of idiopathic pulmonary fibrosis (IPF). However, no study has reported on its prophylactic value against chemotherapy‐associated acute IPF exacerbations when combined with chemotherapy for non‐small cell...
Na minha lista:
| 發表在: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons Australia, Ltd
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7606001/ https://ncbi.nlm.nih.gov/pubmed/32986306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13675 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|